SMARCB1 and cancer: The discovery of biallelic, truncating mutations in the SMARCB1 (INI1, hSNF5, BAF47) gene in atypical teratoid/rhabdoid tumour (AT/RT), a particularly aggressive paediatric cancer, gave the first evidence of their role in carcinogenesis (figure 4) [102].